A luminescence-based protocol for assessing fructose metabolism via quantification of ketohexokinase enzymatic activity in mouse or human hepatocytes.


Journal

STAR protocols
ISSN: 2666-1667
Titre abrégé: STAR Protoc
Pays: United States
ID NLM: 101769501

Informations de publication

Date de publication:
17 09 2021
Historique:
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 20 8 2021
Statut: epublish

Résumé

Ketohexokinase (KHK) catalyzes the first step of fructose metabolism. Inhibitors of KHK enzymatic activity are being evaluated in clinical trials for the treatment of non-alcoholic fatty liver disease (NAFLD) and diabetes. Here, we present a luminescence-based protocol to quantify KHK activity. The accuracy of this technique has been validated using knockdown and overexpression of KHK

Identifiants

pubmed: 34409309
doi: 10.1016/j.xpro.2021.100731
pii: S2666-1667(21)00438-X
pmc: PMC8361265
doi:

Substances chimiques

Fructose 30237-26-4
Fructokinases EC 2.7.1.-
ketohexokinase EC 2.7.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100731

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

L.N. and H.-C.T. are employees of Alnylam Pharmaceuticals Inc. K.W., G.O.M., and J.B. are employees of AstraZeneca.

Références

Cell Metab. 2019 Oct 1;30(4):735-753.e4
pubmed: 31577934
Biochim Biophys Acta. 1984 May 30;772(3):259-63
pubmed: 6722148
Crit Rev Clin Lab Sci. 2020 Aug;57(5):308-322
pubmed: 31935149
J Clin Invest. 2017 Nov 1;127(11):4059-4074
pubmed: 28972537
Int J Obes (Lond). 2021 Nov;45(11):2377-2387
pubmed: 34302121
Clin Transl Sci. 2021 Jan;14(1):11-19
pubmed: 32583961
Physiol Genomics. 2010 Nov 29;42A(4):235-43
pubmed: 20841500
Dig Dis Sci. 2016 May;61(5):1282-93
pubmed: 26856717
Curr Diab Rep. 2020 Oct 15;20(11):64
pubmed: 33057854
Nat Cell Biol. 2016 May;18(5):561-71
pubmed: 27088854
J Histochem Cytochem. 2009 Aug;57(8):763-74
pubmed: 19365088
Diabetes. 2001 Sep;50(9):2139-47
pubmed: 11522682
FEBS Lett. 1989 Sep 11;255(1):175-8
pubmed: 2551726
Eur J Biochem. 1984 Oct 15;144(2):223-6
pubmed: 6386465

Auteurs

Se-Hyung Park (SH)

Department of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, 900 South Limestone, Wethington Rm 527, Lexington, KY 40536, USA.

Robert N Helsley (RN)

Department of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, 900 South Limestone, Wethington Rm 527, Lexington, KY 40536, USA.

Leila Noetzli (L)

Alnylam Pharmaceuticals Inc., Cambridge, MA 021428, USA.

Ho-Chou Tu (HC)

Alnylam Pharmaceuticals Inc., Cambridge, MA 021428, USA.

Kristina Wallenius (K)

Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Gavin O'Mahony (G)

Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Jeremie Boucher (J)

Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
The Lundberg Laboratory for Diabetes Research, University of Gothenburg, Gothenburg, Sweden.
Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.

Jianming Liu (J)

Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Mölndal, Gothenburg 43183, Sweden.

Samir Softic (S)

Department of Pediatrics, Division of Pediatric Gastroenterology, University of Kentucky College of Medicine, 900 South Limestone, Wethington Rm 527, Lexington, KY 40536, USA.
Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH